Patents by Inventor Livio Mallucci

Livio Mallucci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?GBP, compositions comprising ?GBP, and related methods and uses thereof
    Patent number: 7994113
    Abstract: The invention relates to ?-galactoside binding protein (?GBP) and compositions, including pharmaceutical compositions, comprising ?GBP for use in therapy and related applications. In particular, the invention relates to use of ?GBP and the manufacture of medicaments for the treatment or prevention of conditions in which disease associated cell division occurs, wherein the cells which result from said disease associated cell division comprise a cell in respect of which the effect of ?GBP is not inhibition of growth. The invention also relates to methods of inducing apoptosis, methods of treating or preventing conditions in which disease associated cell division occurs and methods of assessing the suitability of ?GBP as a therapeutic agent.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: August 9, 2011
    Inventors: Livio Mallucci, Valerie Wells
  • BetaGBP, compositions comprising betaGBP, and related methods and uses thereof
    Publication number: 20090017049
    Abstract: The invention relates to ?-galactoside binding protein (?GBP) and compositions, including pharmaceutical compositions, comprising ?GBP for use in therapy and related applications. In particular, the invention relates to use of ?GBP and the manufacture of medicaments for the treatment or prevention of conditions in which disease associated cell division occurs, wherein the cells which result from said disease associated cell division comprise a cell in respect of which the effect of ?GBP is not inhibition of growth. The invention also relates to methods of inducing apoptosis, methods of treating or preventing conditions in which disease associated cell division occurs and methods of assessing the suitability of ?GBP as a therapeutic agent.
    Type: Application
    Filed: June 13, 2008
    Publication date: January 15, 2009
    Inventors: Livio Mallucci, Valerie Wells
  • Non-agglutinating .beta.-galactoside binding protein and its encoding nucleic acid
    Patent number: 6127169
    Abstract: Non-agglutinating .beta.-galactoside binding proteins (GBP), both the natural proteins and proteins produced by recombinant DNA technology, are provided for use as inhibitors and regulators of vertebrate cell growth and as anti-viral agents. Methods of producing the GBP's are also described. The GBP's show a powerful growth inhibitory effect against human cancer cells making them potentially useful therapeutic agents in the treatment of malignant disease and also show an inhibitory effect on viral replication making them potentially useful as anti-viral agents.
    Type: Grant
    Filed: April 30, 1993
    Date of Patent: October 3, 2000
    Inventors: Livio Mallucci, Valerie Wells